Chemical Structure (Esbriet 01)
Esbriet
Product Images NDC 50242-121
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esbriet (NDC 50242-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Esbriet 02)
This appears to be a chart or graph depicting the percentage of a certain value (possibly related to lung function) over time, with two groups represented by ESBRIET and Placebo. The chart depicts a decline in the value over time for both groups. There are specific data points labeled on the chart representing the percentage change in the value at specific time points.*
Figure 2 (Esbriet 03)
Figure 3 (Esbriet 04)
This is a clinical trial result of Pirfenidone drug compared to Placebo for patients with a certain medical condition. The table shows the percentage of patients alive, Hazard ratio with confidence interval, patients at risk, and the time frame of the study. There is no information on the medical condition or the purpose of the study.*
Principal Display Panel (267 mg Bottle Carton)
Esbriet (pirfenidone) is a medication that comes in capsule form and is marketed by Genentech. The product is available in a bottle containing 270 capsules and the label warns to keep it out of reach of children. The National Drug Code (NDC) is 50242-121-01.*
Principal Display Panel (267 mg Tablet Bottle Carton)
This is a description of the medication with the NDC code 50242-122-06, marketed under the brand name Esbriet®. The medication contains pirfenidone and is available in tablet form. The label advises to keep the medication away from children and notes that it is only available with a prescription (R' only). The bottle contains 270 tablets and is manufactured by Genentech.*
Principal Display Panel (801 mg Tablet Bottle Carton)
This is a prescription medicine known as Esbriet (pirfenidone). Each bottle contains 90 tablets with the NDC code 50242-123-01 and a strength of 801 mg. The medication should be kept out of reach of children and is only to be used with a valid prescription (R' only). The manufacturer of this medicine is Genentech§.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
